ShockWave Medical, Inc. – NASDAQ:SWAV

Add to watchlist

Market closed

Open in about 10 hours

+1.38%

month

+42.06%

quarter

+19.27%

year

Market Cap	12.56B
Enterprise value	8.98B

P/E	44.12
EV/Sales	18.34
EV/EBITDA	73.22
Price/Sales	18.54
Price/Book	17.76
PEG ratio	0.01
EPS	4.42

Revenue	787.96M
EBITDA	185.11M
Income	163.49M
Revenue Q/Q	35.84%
Revenue Y/Y	41.42%

Profit margin	44.1%
Oper. margin	25.35%
Gross margin	86.73%
EBIT margin	25.35%
EBITDA margin	23.49%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

ShockWave Medical, Inc. (NASDAQ:SWAV): Profit margin
Jun 2023	180.16M	28.86M	16.02%
Sep 2023	186.02M	34.98M	18.81%
Dec 2023	202.97M	44.30M	21.83%
Mar 2024	218.80M	55.34M	25.29%

ShockWave Medical Financials Estimate

Q Y

ShockWave Medical, Inc. (NASDAQ:SWAV): Analyst Estimates
Sep 2025	285.34M	60.74M	21.29%
Oct 2025	287.06M	62.05M	21.62%
Dec 2025	312.84M	68.60M	21.93%
Mar 2026	299.21M	60.98M	20.38%

Analysts Price target
Financials & Ratios estimates

ShockWave Medical, Inc. (NASDAQ:SWAV): Debt to assets
Jun 2023	786604000	169.69M	21.57%
Sep 2023	1473959000	872.71M	59.21%
Dec 2023	1566563000	897.88M	57.32%
Mar 2024	1643747000	891.99M	54.27%

ShockWave Medical, Inc. (NASDAQ:SWAV): Cash Flow
Jun 2023	39.73M	-83.76M	-95.84M
Sep 2023	50.65M	-305.87M	612.99M
Dec 2023	71.70M	-242.26M	-164K
Mar 2024	35.84M	-84.45M	5.01M

ShockWave Medical alternative data

ShockWave Medical
Employees

ShockWave Medical, Inc. (NASDAQ:SWAV): Employee count
Aug 2023	1,001
Sep 2023	1,001
Oct 2023	1,001
Nov 2023	1,001
Dec 2023	1,001
Jan 2024	1,001
Feb 2024	1,001
Mar 2024	1,468
Apr 2024	1,468
May 2024	1,468
Jun 2024	1,468
Jul 2024	1,468

ShockWave Medical
Hedge Funds Holdings Q3 2022

0.08% -0.01%

of SWAV is owned by hedge funds

364 +39

hedge funds hold SWAV stock

30.14M -3.93M

shares is hold by hedge funds

SWAV hedge funds holdings changes

ShockWave Medical
Insider Trading

ShockWave Medical, Inc. (NASDAQ:SWAV): Insider trades (number of shares)
Period	Buy	Sel
Apr 2023	0	10081
May 2023	0	9285
Jun 2023	0	7062
Jul 2023	0	7000
Aug 2023	0	17597
Sep 2023	0	17000
Oct 2023	0	17000
Nov 2023	0	12000
Dec 2023	0	9403
Jan 2024	0	16000
Feb 2024	0	85521
Mar 2024	0	7521

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	17 May 2024	PHUNG TRINH officer: VP, Finance officer: VP, Finance	Stock Option	19,763	$4.72	$93,222
Option	17 May 2024	PHUNG TRINH officer: VP, Finance officer: VP, Finance	Common Stock	16,033	$6.71	$107,581
Option	17 May 2024	PHUNG TRINH officer: VP, Finance officer: VP, Finance	Common Stock	1,339	$3.42	$4,574
Option	17 May 2024	PHUNG TRINH officer: VP, Finance officer: VP, Finance	Common Stock	2,391	$4.03	$9,626
Option	26 Mar 2024	FRANCIS LAURA director	Stock Option	1,500	$6.59	$9,882
Sale	26 Mar 2024	FRANCIS LAURA director	Common Stock	1,500	$300	$450,000
Option	26 Mar 2024	FRANCIS LAURA director	Common Stock	1,500	$6.59	$9,882
Sale	26 Mar 2024	ZACHARIAS ISAAC officer: Presiden..	Common Stock	4,000	$287.67	$1,150,680
Option	6 Mar 2024	WATKINS FRANK T director director	Stock Option	2,000	$3.42	$6,832
Option	6 Mar 2024	WATKINS FRANK T director director	Common Stock	2,000	$3.42	$6,832

SWAV insider trading transactions

Status	Patent	Filling date	Issue date
Application	Application SHOCK WAVE ELECTRODES Filling date: 20 Apr 2022 Issue date: 4 Aug 2022	20 Apr 2022	4 Aug 2022
Application	Application LESION CROSSING SHOCK WAVE CATHETER Filling date: 29 Nov 2021 Issue date: 16 Jun 2022	29 Nov 2021	16 Jun 2022
Grant	Grant Utility: Shock wave electrodes Filling date: 21 Nov 2019 Issue date: 24 May 2022	21 Nov 2019	24 May 2022
Application	Application SYSTEM FOR TREATING THROMBUS IN BODY LUMENS Filling date: 16 Sep 2021 Issue date: 28 Apr 2022	16 Sep 2021	28 Apr 2022
Application	Application LOW PROFILE ELECTRODES FOR AN ANGIOPLASTY SHOCK WAVE CATHETER Filling date: 29 Jun 2021 Issue date: 20 Jan 2022	29 Jun 2021	20 Jan 2022
Application	Application SHOCKWAVE VALVULOPLASTY CATHETER SYSTEM Filling date: 15 Apr 2021 Issue date: 4 Nov 2021	15 Apr 2021	4 Nov 2021
Application	Application SHOCKWAVE CATHETER SYSTEM WITH ENERGY CONTROL Filling date: 10 Mar 2021 Issue date: 23 Sep 2021	10 Mar 2021	23 Sep 2021
Application	Application SHOCKWAVE BALLOON CATHETER SYSTEM Filling date: 2 Mar 2021 Issue date: 16 Sep 2021	2 Mar 2021	16 Sep 2021
Grant	Grant Utility: Low profile electrodes for an angioplasty shock wave catheter Filling date: 4 Jan 2019 Issue date: 3 Aug 2021	4 Jan 2019	3 Aug 2021
Application	Application DEVICE AND METHOD FOR GENERATING FORWARD DIRECTED SHOCK WAVES Filling date: 25 Feb 2021 Issue date: 17 Jun 2021	25 Feb 2021	17 Jun 2021

ShockWave Medical
Earnings Call Transcripts

Quarter	Transcript
Q4 2023 15 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 6 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 7 Aug 2023	Q2 2023 Earnings Call Transcript
Q1 2023 8 May 2023	Q1 2023 Earnings Call Transcript

SWAV earnings call transcripts

ShockWave Medical
Executives

Insider	Age	Compensation
Mr. Douglas E. Godshall (1965) Pres, Chief Executive Officer & Director	60	$972,390
Mr. Isaac Zacharias (1975) Chief Commercial Officer	50	$571,370
Mr. Daniel Puckett (1964) Chief Financial Officer & Sec.	61	$568,340

ShockWave Medical
Latest News

Wednesday, 29 May 2024
17:48	Sarepta Therapeutics Set to Join S&P MidCap 400	prnewswire.com
Monday, 20 May 2024
05:08	Charles Schwab Investment Management Inc. Grows Position in Shockwave Medical, Inc. (NASDAQ:SWAV)	https://www.defenseworld.net
Monday, 13 May 2024
14:08	J&J's $13 billion bid for Shockwave turns to Wall Street for funding	Market Watch
Tuesday, 7 May 2024
11:31	Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y	Zacks Investment Research
Monday, 6 May 2024
22:01	Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates	Zacks Investment Research
18:46	Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates	Zacks Investment Research
11:01	Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release	Zacks Investment Research
Thursday, 25 April 2024
19:21	Why the Market Dipped But Shockwave Medical (SWAV) Gained Today	Zacks Investment Research
Monday, 22 April 2024
09:56	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar	Zacks Investment Research
Friday, 19 April 2024
19:20	Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors	Zacks Investment Research
Tuesday, 16 April 2024
13:05	Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways	Schwab Network
Monday, 15 April 2024
13:15	Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again	Zacks Investment Research
Wednesday, 10 April 2024
08:56	Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left	Zacks Investment Research
Tuesday, 9 April 2024
12:01	Shockwave Medical's (SWAV) Reducer Receives Positive Results	Zacks Investment Research
Monday, 8 April 2024
11:55	Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?	MarketBeat
Friday, 5 April 2024
16:31	Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?	Zacks Investment Research
12:25	J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio	Investopedia
11:12	Johnson & Johnson to acquire medical device company Shockwave Medical for $13.1B	Proactive Investors
11:05	Shockwave Medical Stock Rises After Johnson & Johnson Buyout	Schaeffers Research
10:33	Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal	WSJ
10:01	Johnson & Johnson Buys Shockwave For $13.1 Billion In Latest Cardio Deal	Forbes
09:31	SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson	InvestorPlace
08:10	Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion	Investors Business Daily
07:18	Johnson & Johnson to buy Shockwave Medical for $12.5 billion	Invezz
07:12	Johnson & Johnson to Buy Shockwave Medical. It's a Cardio Health Play.	Barrons
06:40	Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal	Market Watch
06:39	Johnson & Johnson to buy Shockwave Medical for $12.5 bln	Reuters
Monday, 1 April 2024
11:06	Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now	Zacks Investment Research
Friday, 29 March 2024
09:00	Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week	The Motley Fool
Thursday, 28 March 2024
11:06	Shockwave Medical (SWAV) Up on Potential Acquisition Rumors	Zacks Investment Research

Ideas & Opinions

Seeking Alpha 13 Dec 2023

Shockwave Medical: Timing The Waves Of Opportunity
Seeking Alpha 10 Dec 2023

Shockwave Medical: Optimal 2024 Setup For Gains
Seeking Alpha 27 Nov 2023

Buying These 4 Hated Names Devastated By The GLP-1 Hype
Seeking Alpha 8 Nov 2023

Shockwave Medical: Buying The Dip
Seeking Alpha 9 Oct 2023

Shockwave Medical: Interesting Levels Again
Seeking Alpha 14 Aug 2023

The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity
Seeking Alpha 9 Aug 2023

Shockwave Medical: Not Worth The Price
Seeking Alpha 7 Aug 2023

August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 31 Jul 2023

August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 24 May 2023

Shockwave Medical: Multiple Growth Levers To Drive Valuation Upside

Frequently Asked Questions (FAQ)

When is ShockWave Medical's next earnings date?

Unfortunately, ShockWave Medical's (SWAV) next earnings date is currently unknown.
Does ShockWave Medical pay dividends?

No, ShockWave Medical does not pay dividends.
How much money does ShockWave Medical make?

ShockWave Medical has a market capitalization of 12.56B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49.11% to 730.23M US dollars.
What is ShockWave Medical's stock symbol?

ShockWave Medical, Inc. is traded on the NASDAQ under the ticker symbol "SWAV".
What is ShockWave Medical's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of ShockWave Medical?

Shares of ShockWave Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are ShockWave Medical's key executives?
ShockWave Medical's management team includes the following people:
- Mr. Douglas E. Godshall Pres, Chief Executive Officer & Director(age: 60, pay: $972,390)
- Mr. Isaac Zacharias Chief Commercial Officer(age: 50, pay: $571,370)
- Mr. Daniel Puckett Chief Financial Officer & Sec.(age: 61, pay: $568,340)
How many employees does ShockWave Medical have?

As Jul 2024, ShockWave Medical employs 1,468 workers.
When ShockWave Medical went public?

ShockWave Medical, Inc. is publicly traded company for more then 6 years since IPO on 7 Mar 2019.
What is ShockWave Medical's official website?

The official website for ShockWave Medical is shockwavemedical.com.
Where are ShockWave Medical's headquarters?

ShockWave Medical is headquartered at 5403 Betsy Ross Drive, Santa Clara, CA.
How can i contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara, CA and company can be reached via phone at +51 02794262.

ShockWave Medical, Inc.

shockwavemedical.com

Exchange:

NASDAQ

Full time employees:

1,468

Industry:

Medical - Devices

Sector:

Healthcare

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

+51 02794262

5403 Betsy Ross Drive
Santa Clara, CA 95054

CIK: 0001642545
ISIN: US82489T1043
CUSIP: 82489T104